Saturday, July 03, 2021 2:23:43 PM
A combination of NRXP and RLF and their new subsidiaries would make a nice midcap Pharma, IMO. The prices are right for GEM to support a NRLA, IMO. NRXP+RLF+ACER++=NRLA...
They 'could' force this BS feud to end. JJ is 'RICH' now so maybe there could be reasonable common efforts. Sad this has fumbled so often, had cumulative delays, problems with some Data which resulted in less than stellar results and lack of cooperation.
A consolidation of Drugs and shares structures and debt and talent might be the answer to again attract interest without this current BS...JMHO...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM